Polyamine synthesis and transport inhibition in a human anaplastic thyroid carcinoma cell line in vitro and as xenograft tumors.
Polyamine synthesis and transport inhibition in a human anaplastic thyroid carcinoma cell line in vitro and as xenograft tumors.
复制标题
体外人类未变性甲状腺癌细胞系和异种移植肿瘤中的多胺合成和运输抑制。
DOI:
10.1089/thy.1999.9.805
复制
发表时间:
1999
期刊:
影响因子:
--
通讯作者:
Ain,KB
中科院分区:
文献类型:
--
作者:
Yatin,M;Venkataraman,GM;Marcinek,R;Ain,KB
Polyamines are essential cellular components for neoplastic transformation and cell proliferation. Antineoplastic efforts that inhibit polyamine synthesis are insufficient to induce cytotoxicity, due to compensatory induction of polyamine transport. Treatment of an anaplastic human thyroid carcinoma cell line (DRO90-1) with a novel polymeric spermine conjugate (polyspermine; PSpm) causedin vitrocytotoxicity and inhibited the growth of xenograft tumors at low concentrations. Similarin vitroantineoplastic effects were noted with two other human anaplastic thyroid carcinoma cell lines. This coincided with inhibition of polyamine uptake and synthetic enzyme activities, with reduced ornithine decarboxylase (ODC) and S-adenosylmethionine decarboxylase (SAM-DC) but increased spermidine/spermine N1-acetyltransferase (SSAT) activities, as measured in DRO90-1 cells. In subsequent studies using these cells, PSpm was effective in reducing the intracellular levels of all polyaminesin vitro, resulting in cytotoxicity that was not reversed by administration of extracellular polyamines. Low-dose PSpm inhibited tumor growthin vivo, but high doses of PSpm potentiated xenograft tumor growth. PSpm degradation products produced within vivotreatment may be produced that function as substrates for polyamine biosynthesis. These studies suggest that polyamine metabolism inhibition is a viable target for antineoplastic therapy of anaplastic thyroid carcinoma, although thein vivoresponse to PSpm suggests that this agent will have limited clinical utility.
登录
查看更多内容
DOI:
10.1093/jnci/83.11.757
发表时间:
1991-06-05
期刊:
JOURNAL OF THE NATIONAL CANCER INSTITUTE
影响因子:
--
作者:
MONKS, A;SCUDIERO, D;BOYD, M
通讯作者:
BOYD, M
影响因子:
11.2
作者:
Porter,CW;Ganis,B;Vinson,T;Marton,LJ;Kramer,DL;Bergeron,RJ
通讯作者:
Bergeron,RJ
DOI:
10.1042/bj3200755
发表时间:
1996
期刊:
The Biochemical journal
影响因子:
--
作者:
Mitchell,JL;Choe,CY;Judd,GG
通讯作者:
Judd,GG
影响因子:
7.3
作者:
BERGERON, RJ;MCMANIS, JS;VINSON, JRT
通讯作者:
VINSON, JRT
影响因子:
11.2
作者:
Anthony E. Pegg
通讯作者:
Anthony E. Pegg